128 related articles for article (PubMed ID: 18660676)
21. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
Templeton DM
Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
[TBL] [Abstract][Full Text] [Related]
22. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
23. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
[TBL] [Abstract][Full Text] [Related]
24. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats.
Rada JA; Carlson EC
Anat Rec; 1991 Sep; 231(1):35-47. PubMed ID: 1750710
[TBL] [Abstract][Full Text] [Related]
25. The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.
McCarthy KJ; Wassenhove-McCarthy DJ
Microsc Microanal; 2012 Feb; 18(1):3-21. PubMed ID: 22258721
[TBL] [Abstract][Full Text] [Related]
26. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
27. The role of heparan sulfate in the glomerular basement membrane.
Morita H; Yoshimura A; Kimata K
Kidney Int; 2008 Feb; 73(3):247-8. PubMed ID: 18195692
[TBL] [Abstract][Full Text] [Related]
28. Characterization of heparan sulfate isolated from drug glomerular basement membranes.
Linker A; Hovingh P; Kanwar YS; Farquhar MG
Lab Invest; 1981 Jun; 44(6):560-5. PubMed ID: 6453253
[TBL] [Abstract][Full Text] [Related]
29. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria.
Chen S; Wassenhove-McCarthy DJ; Yamaguchi Y; Holzman LB; van Kuppevelt TH; Jenniskens GJ; Wijnhoven TJ; Woods AC; McCarthy KJ
Kidney Int; 2008 Aug; 74(3):289-99. PubMed ID: 18480751
[TBL] [Abstract][Full Text] [Related]
30. Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane.
Miner JH
Organogenesis; 2011; 7(2):75-82. PubMed ID: 21519194
[TBL] [Abstract][Full Text] [Related]
31. [Biophysicochemical structures of the glomerular filter].
Langer KH
Klin Wochenschr; 1985 Sep; 63(18):835-49. PubMed ID: 4057915
[TBL] [Abstract][Full Text] [Related]
32. Update on the glomerular filtration barrier.
Jarad G; Miner JH
Curr Opin Nephrol Hypertens; 2009 May; 18(3):226-32. PubMed ID: 19374010
[TBL] [Abstract][Full Text] [Related]
33. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
34. Regulation of glomerular endothelial cell proteoglycans by glucose.
Ha TS; Duraisamy S; Faulkner JL; Kasinath BS
J Korean Med Sci; 2004 Apr; 19(2):245-52. PubMed ID: 15082898
[TBL] [Abstract][Full Text] [Related]
35. Cationic colloidal gold--a novel marker for the demonstration of glomerular polyanion status in routine renal biopsies.
Goode NP; Shires M; Aparicio SR; Davison AM
Nephrol Dial Transplant; 1991; 6(12):923-30. PubMed ID: 1724690
[TBL] [Abstract][Full Text] [Related]
36. New insights into the molecular biology of the glomerular filtration barrier and associated disease.
Levidiotis V; Power DA
Nephrology (Carlton); 2005 Apr; 10(2):157-66. PubMed ID: 15877676
[TBL] [Abstract][Full Text] [Related]
37. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.
Wijnhoven TJ; Lensen JF; Wismans RG; Lefeber DJ; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Dec; 18(12):3119-27. PubMed ID: 18003778
[TBL] [Abstract][Full Text] [Related]
38. Anti-proteinuric effects of glycosaminoglycan-based drugs.
Wijnhoven T; Lensen JF; Rops AL; McCarthy KJ; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
Curr Opin Mol Ther; 2007 Aug; 9(4):364-77. PubMed ID: 17694449
[TBL] [Abstract][Full Text] [Related]
39. Dexamethasone increases heparan sulfate proteoglycan core protein content of glomerular epithelial cells.
Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
J Lab Clin Med; 1990 Feb; 115(2):196-202. PubMed ID: 2137158
[TBL] [Abstract][Full Text] [Related]
40. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis.
Patel VN; Knox SM; Likar KM; Lathrop CA; Hossain R; Eftekhari S; Whitelock JM; Elkin M; Vlodavsky I; Hoffman MP
Development; 2007 Dec; 134(23):4177-86. PubMed ID: 17959718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
